| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 4.80e-14 | 16 | 69 | 7 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.81e-13 | 21 | 69 | 7 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.37e-11 | 85 | 69 | 9 | GO:0038024 | |
| GeneOntologyMolecularFunction | calcium ion binding | NELL1 THBS1 EYS STAB2 EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 3.06e-08 | 749 | 69 | 15 | GO:0005509 |
| GeneOntologyMolecularFunction | K48-linked polyubiquitin modification-dependent protein binding | 4.66e-06 | 10 | 69 | 3 | GO:0036435 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 3.10e-05 | 18 | 69 | 3 | GO:0030169 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 5.15e-05 | 59 | 69 | 4 | GO:0031593 | |
| GeneOntologyMolecularFunction | cysteine-type carboxypeptidase activity | 7.03e-05 | 4 | 69 | 2 | GO:0016807 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase activity | 7.54e-05 | 65 | 69 | 4 | GO:0004714 | |
| GeneOntologyMolecularFunction | K63-linked polyubiquitin modification-dependent protein binding | 9.70e-05 | 26 | 69 | 3 | GO:0070530 | |
| GeneOntologyMolecularFunction | growth factor binding | 2.05e-04 | 156 | 69 | 5 | GO:0019838 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 2.14e-04 | 85 | 69 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 2.39e-04 | 35 | 69 | 3 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 2.39e-04 | 35 | 69 | 3 | GO:0071814 | |
| GeneOntologyMolecularFunction | cysteine-type exopeptidase activity | 5.20e-04 | 10 | 69 | 2 | GO:0070004 | |
| GeneOntologyMolecularFunction | voltage-gated chloride channel activity | 6.34e-04 | 11 | 69 | 2 | GO:0005247 | |
| GeneOntologyMolecularFunction | modification-dependent protein binding | 7.32e-04 | 206 | 69 | 5 | GO:0140030 | |
| GeneOntologyMolecularFunction | clathrin heavy chain binding | 7.60e-04 | 12 | 69 | 2 | GO:0032050 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 8.71e-04 | 323 | 69 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | insulin-like growth factor I binding | 8.96e-04 | 13 | 69 | 2 | GO:0031994 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic anion channel activity | 1.55e-03 | 17 | 69 | 2 | GO:0008308 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 1.60e-03 | 145 | 69 | 4 | GO:0004713 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.94e-03 | 19 | 69 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 2.15e-03 | 20 | 69 | 2 | GO:0034185 | |
| GeneOntologyMolecularFunction | K48-linked deubiquitinase activity | 2.37e-03 | 21 | 69 | 2 | GO:1990380 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZFP3 LMX1B GLI1 GLI3 SKOR2 ZNF329 ZNF566 NFX1 ZNF415 NOTCH1 NOTCH2 ZIC2 | 3.05e-03 | 1412 | 69 | 12 | GO:0000981 |
| GeneOntologyMolecularFunction | zinc ion binding | 3.46e-03 | 891 | 69 | 9 | GO:0008270 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 3.63e-03 | 26 | 69 | 2 | GO:0050431 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.91e-03 | 27 | 69 | 2 | GO:0005044 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 4.09e-03 | 188 | 69 | 4 | GO:0005201 | |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.40e-07 | 178 | 69 | 8 | GO:0022612 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | CSF1R EGF KIF26B GLI3 LAMA1 LRP2 LRP6 SHANK3 NOTCH1 NOTCH2 ZIC2 | 1.42e-07 | 421 | 69 | 11 | GO:0060562 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 3.57e-07 | 5 | 69 | 3 | GO:1905167 | |
| GeneOntologyBiologicalProcess | axon guidance | 4.44e-07 | 285 | 69 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 4.57e-07 | 286 | 69 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | THBS1 STAB2 CSF1R EGF KIF26B GLI1 GLI3 LAMA1 LRP1 LRP2 LRP6 LDLR SHANK3 NOTCH1 NOTCH2 ZIC2 | 6.83e-07 | 1125 | 69 | 16 | GO:0035239 |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 1.09e-06 | 233 | 69 | 8 | GO:0061351 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.24e-06 | 7 | 69 | 3 | GO:1904352 | |
| GeneOntologyBiologicalProcess | gliogenesis | 1.76e-06 | 435 | 69 | 10 | GO:0042063 | |
| GeneOntologyBiologicalProcess | receptor-mediated endocytosis | 1.79e-06 | 337 | 69 | 9 | GO:0006898 | |
| GeneOntologyBiologicalProcess | tube development | THBS1 STAB2 CSF1R EGF KIF26B GLI1 GLI3 LAMA1 LRP1 LRP2 LRP6 UMOD LDLR SHANK3 NOTCH1 NOTCH2 ZIC2 | 2.58e-06 | 1402 | 69 | 17 | GO:0035295 |
| GeneOntologyBiologicalProcess | regulation of neural precursor cell proliferation | 6.01e-06 | 135 | 69 | 6 | GO:2000177 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | CSF1R EGF KIF26B GLI3 LAMA1 LRP2 LRP6 SHANK3 NOTCH1 NOTCH2 ZIC2 | 6.11e-06 | 619 | 69 | 11 | GO:0002009 |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 7.16e-06 | 80 | 69 | 5 | GO:2000179 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 7.71e-06 | 12 | 69 | 3 | GO:1905165 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance | 9.57e-06 | 40 | 69 | 4 | GO:0097242 | |
| GeneOntologyBiologicalProcess | regulation of protein catabolic process in the vacuole | 1.27e-05 | 14 | 69 | 3 | GO:1904350 | |
| GeneOntologyBiologicalProcess | gland development | 1.57e-05 | 558 | 69 | 10 | GO:0048732 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 1.68e-05 | 445 | 69 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | endocytosis | LRP12 THBS1 STAB2 EGF CLCN5 ASGR1 INSR LRP1 LRP2 LRP6 LRP1B LDLR | 1.71e-05 | 827 | 69 | 12 | GO:0006897 |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.03e-05 | 347 | 69 | 8 | GO:0090092 | |
| GeneOntologyBiologicalProcess | neuroblast proliferation | 2.57e-05 | 104 | 69 | 5 | GO:0007405 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 3.15e-05 | 482 | 69 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 3.30e-05 | 3 | 69 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 3.37e-05 | 110 | 69 | 5 | GO:0072080 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | CSF1R HMCN2 GLI3 SKOR2 LAMA1 LRP1 LRP2 SHANK3 NOTCH1 NOTCH2 ZIC2 | 3.55e-05 | 748 | 69 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | tissue morphogenesis | CSF1R EGF KIF26B GLI3 LAMA1 LRP2 LRP6 SHANK3 NOTCH1 NOTCH2 ZIC2 | 3.64e-05 | 750 | 69 | 11 | GO:0048729 |
| GeneOntologyBiologicalProcess | tube formation | 3.82e-05 | 187 | 69 | 6 | GO:0035148 | |
| GeneOntologyBiologicalProcess | heart development | PRICKLE4 THBS1 GLI1 GLI3 INSR LRP1 LRP2 LRP6 TAB2 NOTCH1 NOTCH2 | 3.96e-05 | 757 | 69 | 11 | GO:0007507 |
| GeneOntologyBiologicalProcess | renal tubule development | 4.35e-05 | 116 | 69 | 5 | GO:0061326 | |
| GeneOntologyBiologicalProcess | developmental growth | THBS1 EYS CSF1R LMX1B KIF26B GLI1 GLI3 INSR LRP1 LRP6 NOTCH1 NOTCH2 | 4.42e-05 | 911 | 69 | 12 | GO:0048589 |
| GeneOntologyBiologicalProcess | cerebellum morphogenesis | 4.86e-05 | 60 | 69 | 4 | GO:0021587 | |
| GeneOntologyBiologicalProcess | hindbrain morphogenesis | 6.26e-05 | 64 | 69 | 4 | GO:0021575 | |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 6.66e-05 | 65 | 69 | 4 | GO:0021872 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | CSF1R HMCN2 GLI3 SKOR2 LAMA1 LRP1 LRP2 SHANK3 NOTCH1 NOTCH2 ZIC2 | 6.67e-05 | 802 | 69 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | circulatory system development | PRICKLE4 THBS1 STAB2 EGF GLI1 GLI3 INSR LAMA1 LRP1 LRP2 LRP6 TAB2 LDLR NOTCH1 NOTCH2 | 6.76e-05 | 1442 | 69 | 15 | GO:0072359 |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 6.83e-05 | 412 | 69 | 8 | GO:0090287 | |
| GeneOntologyBiologicalProcess | lysosomal protein catabolic process | 6.90e-05 | 24 | 69 | 3 | GO:1905146 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 6.96e-05 | 128 | 69 | 5 | GO:0072009 | |
| GeneOntologyBiologicalProcess | regulation of neuroblast proliferation | 7.50e-05 | 67 | 69 | 4 | GO:1902692 | |
| GeneOntologyBiologicalProcess | neuron projection development | LRP12 EFEMP1 CSF1R HMCN2 GLI3 SKOR2 LAMA1 LRP1 LRP2 LRP6 SHANK3 NOTCH1 NOTCH2 ZIC2 | 7.55e-05 | 1285 | 69 | 14 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 7.77e-05 | 131 | 69 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | neuron development | LRP12 EFEMP1 CSF1R HMCN2 LMX1B GLI3 SKOR2 LAMA1 LRP1 LRP2 LRP6 SHANK3 NOTCH1 NOTCH2 ZIC2 | 7.96e-05 | 1463 | 69 | 15 | GO:0048666 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | CSF1R HMCN2 GLI3 SKOR2 LAMA1 LRP1 LRP2 SHANK3 NOTCH1 NOTCH2 ZIC2 | 8.04e-05 | 819 | 69 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | artery development | 8.35e-05 | 133 | 69 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 8.65e-05 | 134 | 69 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | CSF1R HMCN2 GLI3 SKOR2 LAMA1 LRP1 LRP2 SHANK3 NOTCH1 NOTCH2 ZIC2 | 8.67e-05 | 826 | 69 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 8.96e-05 | 218 | 69 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | glial cell differentiation | 9.78e-05 | 321 | 69 | 7 | GO:0010001 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.08e-04 | 566 | 69 | 9 | GO:0007409 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 1.10e-04 | 5 | 69 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | protein catabolic process in the vacuole | 1.11e-04 | 28 | 69 | 3 | GO:0007039 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 1.11e-04 | 74 | 69 | 4 | GO:0002011 | |
| GeneOntologyBiologicalProcess | brain development | CSF1R EGF LMX1B GLI1 GLI3 SKOR2 LRP2 LRP6 SHANK3 NOTCH1 ZIC2 | 1.23e-04 | 859 | 69 | 11 | GO:0007420 |
| GeneOntologyBiologicalProcess | astrocyte activation | 1.23e-04 | 29 | 69 | 3 | GO:0048143 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | THBS1 EFEMP1 CSF1R EGF CRIM1 SKOR2 WFIKKN2 INSR LRP1 LRP2 NOTCH1 NOTCH2 ZIC2 | 1.34e-04 | 1186 | 69 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | embryonic limb morphogenesis | 1.38e-04 | 148 | 69 | 5 | GO:0030326 | |
| GeneOntologyBiologicalProcess | embryonic appendage morphogenesis | 1.38e-04 | 148 | 69 | 5 | GO:0035113 | |
| GeneOntologyBiologicalProcess | central nervous system development | CSF1R EGF LMX1B GLI1 GLI3 SKOR2 LRP1 LRP2 LRP6 LDLR SHANK3 NOTCH1 ZIC2 | 1.47e-04 | 1197 | 69 | 13 | GO:0007417 |
| GeneOntologyBiologicalProcess | negative regulation of cellular response to growth factor stimulus | 1.47e-04 | 150 | 69 | 5 | GO:0090288 | |
| GeneOntologyBiologicalProcess | negative regulation of BMP signaling pathway | 1.50e-04 | 80 | 69 | 4 | GO:0030514 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.79e-04 | 354 | 69 | 7 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regionalization | 1.90e-04 | 478 | 69 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | growth | LRP12 THBS1 EYS CSF1R LMX1B KIF26B GLI1 GLI3 INSR LRP1 LRP6 NOTCH1 NOTCH2 | 2.00e-04 | 1235 | 69 | 13 | GO:0040007 |
| GeneOntologyBiologicalProcess | import into cell | LRP12 THBS1 STAB2 EGF CLCN5 ASGR1 INSR LRP1 LRP2 LRP6 LRP1B LDLR | 2.10e-04 | 1074 | 69 | 12 | GO:0098657 |
| GeneOntologyBiologicalProcess | kidney epithelium development | 2.11e-04 | 162 | 69 | 5 | GO:0072073 | |
| GeneOntologyBiologicalProcess | head development | CSF1R EGF LMX1B GLI1 GLI3 SKOR2 LRP2 LRP6 SHANK3 NOTCH1 ZIC2 | 2.21e-04 | 919 | 69 | 11 | GO:0060322 |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 2.26e-04 | 89 | 69 | 4 | GO:0060411 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.28e-04 | 625 | 69 | 9 | GO:0051960 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell chemotaxis | 2.29e-04 | 7 | 69 | 2 | GO:2001027 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 2.43e-04 | 262 | 69 | 6 | GO:0048771 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.57e-04 | 92 | 69 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | THBS1 CSF1R KIF26B GLI1 GLI3 INSR LAMA1 LRP2 LRP6 FGL1 SHANK3 NOTCH1 NOTCH2 | 2.60e-04 | 1269 | 69 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | axon development | 2.78e-04 | 642 | 69 | 9 | GO:0061564 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 2.79e-04 | 94 | 69 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | epithelial tube formation | 2.85e-04 | 173 | 69 | 5 | GO:0072175 | |
| GeneOntologyBiologicalProcess | nephron development | 2.93e-04 | 174 | 69 | 5 | GO:0072006 | |
| GeneOntologyBiologicalProcess | amyloid-beta clearance by cellular catabolic process | 3.05e-04 | 8 | 69 | 2 | GO:0150094 | |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | 3.14e-04 | 515 | 69 | 8 | GO:0050767 | |
| GeneOntologyBiologicalProcess | regulation of embryonic development | 3.40e-04 | 99 | 69 | 4 | GO:0045995 | |
| GeneOntologyBiologicalProcess | pattern specification process | 3.62e-04 | 526 | 69 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | appendage morphogenesis | 3.88e-04 | 185 | 69 | 5 | GO:0035107 | |
| GeneOntologyBiologicalProcess | limb morphogenesis | 3.88e-04 | 185 | 69 | 5 | GO:0035108 | |
| GeneOntologyBiologicalProcess | mammary gland formation | 3.91e-04 | 9 | 69 | 2 | GO:0060592 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte activation | 3.91e-04 | 9 | 69 | 2 | GO:0061888 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 3.91e-04 | 9 | 69 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | forebrain radial glial cell differentiation | 3.91e-04 | 9 | 69 | 2 | GO:0021861 | |
| GeneOntologyBiologicalProcess | pericardium morphogenesis | 3.91e-04 | 9 | 69 | 2 | GO:0003344 | |
| GeneOntologyBiologicalProcess | cell surface receptor signaling pathway involved in heart development | 3.91e-04 | 9 | 69 | 2 | GO:0061311 | |
| GeneOntologyBiologicalProcess | regulation of astrocyte differentiation | 4.02e-04 | 43 | 69 | 3 | GO:0048710 | |
| GeneOntologyBiologicalProcess | astrocyte differentiation | 4.25e-04 | 105 | 69 | 4 | GO:0048708 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 4.30e-04 | 44 | 69 | 3 | GO:0002052 | |
| GeneOntologyBiologicalProcess | dorsal/ventral pattern formation | 4.57e-04 | 107 | 69 | 4 | GO:0009953 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 4.60e-04 | 192 | 69 | 5 | GO:0045667 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 4.88e-04 | 10 | 69 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | regulation of cerebellar granule cell precursor proliferation | 4.88e-04 | 10 | 69 | 2 | GO:0021936 | |
| GeneOntologyBiologicalProcess | distal tubule development | 4.88e-04 | 10 | 69 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 4.88e-04 | 418 | 69 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 4.91e-04 | 46 | 69 | 3 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 4.91e-04 | 46 | 69 | 3 | GO:0072574 | |
| GeneOntologyCellularComponent | cell surface | THBS1 STAB2 CD5L CSF1R ASGR1 CD163L1 INSR LRP1 LRP2 LRP6 UMOD CORIN SCART1 LDLR NOTCH1 NOTCH2 | 4.84e-07 | 1111 | 69 | 16 | GO:0009986 |
| GeneOntologyCellularComponent | external side of plasma membrane | 5.05e-05 | 519 | 69 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | GLI-SUFU complex | 6.42e-05 | 4 | 69 | 2 | GO:1990788 | |
| GeneOntologyCellularComponent | receptor complex | 1.19e-04 | 581 | 69 | 9 | GO:0043235 | |
| GeneOntologyCellularComponent | side of membrane | THBS1 STAB2 RNF31 ASGR1 CD163L1 INSR LRP1 LRP2 UMOD SCART1 LDLR | 1.28e-04 | 875 | 69 | 11 | GO:0098552 |
| GeneOntologyCellularComponent | lysosomal membrane | 1.38e-04 | 462 | 69 | 8 | GO:0005765 | |
| GeneOntologyCellularComponent | lytic vacuole membrane | 1.38e-04 | 462 | 69 | 8 | GO:0098852 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.42e-04 | 80 | 69 | 4 | GO:0005905 | |
| GeneOntologyCellularComponent | vacuolar membrane | 2.59e-04 | 507 | 69 | 8 | GO:0005774 | |
| GeneOntologyCellularComponent | fibrinogen complex | 2.97e-04 | 8 | 69 | 2 | GO:0005577 | |
| GeneOntologyCellularComponent | endocytic vesicle membrane | 6.79e-04 | 212 | 69 | 5 | GO:0030666 | |
| GeneOntologyCellularComponent | basement membrane | 7.12e-04 | 122 | 69 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | ciliary base | 8.42e-04 | 56 | 69 | 3 | GO:0097546 | |
| GeneOntologyCellularComponent | lysosome | 1.34e-03 | 811 | 69 | 9 | GO:0005764 | |
| GeneOntologyCellularComponent | lytic vacuole | 1.34e-03 | 811 | 69 | 9 | GO:0000323 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 1.80e-03 | 530 | 69 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle membrane | 2.27e-03 | 79 | 69 | 3 | GO:0030669 | |
| GeneOntologyCellularComponent | vacuole | 3.00e-03 | 913 | 69 | 9 | GO:0005773 | |
| GeneOntologyCellularComponent | apical part of cell | 3.33e-03 | 592 | 69 | 7 | GO:0045177 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | 3.51e-03 | 1307 | 69 | 11 | GO:0030659 | |
| GeneOntologyCellularComponent | endosome membrane | 3.66e-03 | 602 | 69 | 7 | GO:0010008 | |
| GeneOntologyCellularComponent | vesicle membrane | 3.89e-03 | 1325 | 69 | 11 | GO:0012506 | |
| GeneOntologyCellularComponent | clathrin-coated endocytic vesicle | 4.55e-03 | 101 | 69 | 3 | GO:0045334 | |
| GeneOntologyCellularComponent | extracellular matrix | 5.82e-03 | 656 | 69 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 5.91e-03 | 658 | 69 | 7 | GO:0030312 | |
| GeneOntologyCellularComponent | caveola | 5.92e-03 | 111 | 69 | 3 | GO:0005901 | |
| MousePheno | decreased circulating transferrin level | 7.56e-06 | 10 | 57 | 3 | MP:0011894 | |
| MousePheno | abnormal kidney corticomedullary boundary morphology | 2.27e-05 | 14 | 57 | 3 | MP:0011376 | |
| MousePheno | abnormal midbrain-hindbrain boundary morphology | 2.82e-05 | 15 | 57 | 3 | MP:0012132 | |
| MousePheno | abnormal capillary morphology | 3.73e-05 | 93 | 57 | 5 | MP:0003658 | |
| MousePheno | abnormal rhombomere morphology | 4.20e-05 | 17 | 57 | 3 | MP:0000933 | |
| MousePheno | abnormal brain commissure morphology | 4.75e-05 | 161 | 57 | 6 | MP:0002199 | |
| MousePheno | increased urine microglobulin level | 4.89e-05 | 3 | 57 | 2 | MP:0011555 | |
| MousePheno | abnormal neuromere morphology | 5.02e-05 | 18 | 57 | 3 | MP:0003208 | |
| MousePheno | abnormal kidney apoptosis | 6.27e-05 | 53 | 57 | 4 | MP:0011367 | |
| MousePheno | herniated abdominal wall | 6.98e-05 | 20 | 57 | 3 | MP:0000757 | |
| MousePheno | abnormal glomerular capillary endothelium morphology | 8.11e-05 | 21 | 57 | 3 | MP:0011453 | |
| MousePheno | abnormal circulating transferrin level | 9.37e-05 | 22 | 57 | 3 | MP:0011892 | |
| MousePheno | microphthalmia | 1.02e-04 | 362 | 57 | 8 | MP:0001297 | |
| MousePheno | abnormal nervous system tract morphology | 1.15e-04 | 189 | 57 | 6 | MP:0000778 | |
| MousePheno | abnormal eye size | 1.30e-04 | 375 | 57 | 8 | MP:0002697 | |
| MousePheno | absent glomerular endothelium fenestra | 1.62e-04 | 5 | 57 | 2 | MP:0011455 | |
| MousePheno | abnormal brain white matter morphology | 1.85e-04 | 206 | 57 | 6 | MP:0008026 | |
| MousePheno | abnormal liver physiology | 2.06e-04 | 401 | 57 | 8 | MP:0000609 | |
| MousePheno | delayed neural tube closure | 2.66e-04 | 31 | 57 | 3 | MP:0002621 | |
| MousePheno | abnormal vertebral column morphology | NELL1 THBS1 EFEMP1 TMEM248 CLCN5 CRIM1 GLI3 LRP6 NOTCH1 NOTCH2 ZIC2 | 2.86e-04 | 787 | 57 | 11 | MP:0004703 |
| MousePheno | abnormal abdominal wall morphology | 3.43e-04 | 82 | 57 | 4 | MP:0003257 | |
| MousePheno | abnormal hepatobiliary system physiology | 3.47e-04 | 433 | 57 | 8 | MP:0002139 | |
| MousePheno | abnormal tectum morphology | 3.83e-04 | 35 | 57 | 3 | MP:0006104 | |
| MousePheno | abnormal midbrain roof plate morphology | 3.83e-04 | 35 | 57 | 3 | MP:0006103 | |
| MousePheno | abnormal corpora quadrigemina morphology | 3.83e-04 | 35 | 57 | 3 | MP:0000899 | |
| MousePheno | decreased circulating unsaturated transferrin level | 4.50e-04 | 8 | 57 | 2 | MP:0011897 | |
| MousePheno | abnormal choriocapillaris morphology | 4.50e-04 | 8 | 57 | 2 | MP:0006238 | |
| MousePheno | vertebral fusion | 5.20e-04 | 163 | 57 | 5 | MP:0004609 | |
| MousePheno | abnormal hindbrain development | 5.35e-04 | 164 | 57 | 5 | MP:0006108 | |
| MousePheno | perinatal lethality, complete penetrance | 5.41e-04 | 712 | 57 | 10 | MP:0011089 | |
| MousePheno | abnormal axial skeleton morphology | NELL1 THBS1 EFEMP1 CSF1R TMEM248 CLCN5 CRIM1 LMX1B GLI3 PEDS1 LRP2 LRP6 NOTCH1 NOTCH2 ZIC2 | 5.60e-04 | 1458 | 57 | 15 | MP:0002114 |
| MousePheno | abnormal glomerular endothelium fenestra morphology | 5.77e-04 | 9 | 57 | 2 | MP:0011454 | |
| MousePheno | fused tarsal bones | 5.77e-04 | 9 | 57 | 2 | MP:0008919 | |
| MousePheno | fused joints | 6.30e-04 | 170 | 57 | 5 | MP:0003189 | |
| MousePheno | abnormal urine protein level | 6.30e-04 | 170 | 57 | 5 | MP:0006315 | |
| MousePheno | abnormal nail morphology | 7.07e-04 | 43 | 57 | 3 | MP:0000579 | |
| MousePheno | increased kidney apoptosis | 7.07e-04 | 43 | 57 | 3 | MP:0011368 | |
| Domain | Growth_fac_rcpt_ | NELL1 EYS STAB2 EFEMP1 HMCN2 EGF CRIM1 INSR LAMA1 LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 4.53e-21 | 156 | 67 | 17 | IPR009030 |
| Domain | EGF_CA | NELL1 THBS1 EYS STAB2 EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 1.80e-19 | 122 | 67 | 15 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | NELL1 THBS1 EYS STAB2 EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 2.32e-19 | 124 | 67 | 15 | IPR001881 |
| Domain | EGF-like_dom | NELL1 THBS1 EYS CNTNAP5 STAB2 EFEMP1 HMCN2 EGF LAMA1 LRP1 LRP2 LRP6 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 5.00e-19 | 249 | 67 | 18 | IPR000742 |
| Domain | EGF_1 | NELL1 THBS1 EYS CNTNAP5 STAB2 EFEMP1 HMCN2 EGF LAMA1 LRP1 LRP2 LRP6 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 7.67e-19 | 255 | 67 | 18 | PS00022 |
| Domain | EGF_2 | NELL1 THBS1 EYS CNTNAP5 STAB2 EFEMP1 HMCN2 EGF LAMA1 LRP1 LRP2 LRP6 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 1.53e-18 | 265 | 67 | 18 | PS01186 |
| Domain | EGF_CA | NELL1 THBS1 EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 3.37e-18 | 86 | 67 | 13 | PF07645 |
| Domain | EGF_3 | NELL1 THBS1 EYS CNTNAP5 STAB2 EFEMP1 HMCN2 EGF LRP1 LRP2 LRP6 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 5.35e-18 | 235 | 67 | 17 | PS50026 |
| Domain | EGF | NELL1 THBS1 EYS CNTNAP5 STAB2 EFEMP1 EGF LAMA1 LRP1 LRP2 LRP6 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 5.35e-18 | 235 | 67 | 17 | SM00181 |
| Domain | EGF_Ca-bd_CS | NELL1 EYS EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 1.75e-17 | 97 | 67 | 13 | IPR018097 |
| Domain | EGF_CA | NELL1 EYS EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 2.31e-17 | 99 | 67 | 13 | PS01187 |
| Domain | ASX_HYDROXYL | NELL1 EYS EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 2.65e-17 | 100 | 67 | 13 | PS00010 |
| Domain | EGF-like_CS | NELL1 THBS1 EYS STAB2 EFEMP1 HMCN2 EGF LAMA1 LRP1 LRP2 LRP6 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 3.17e-17 | 261 | 67 | 17 | IPR013032 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | NELL1 EYS EFEMP1 HMCN2 EGF LRP1 LRP2 UMOD LRP1B LDLR NOTCH1 NOTCH2 EGFL6 | 5.84e-17 | 106 | 67 | 13 | IPR000152 |
| Domain | Ldl_recept_b | 4.97e-12 | 14 | 67 | 6 | PF00058 | |
| Domain | LDLRB | 4.97e-12 | 14 | 67 | 6 | PS51120 | |
| Domain | LY | 8.27e-12 | 15 | 67 | 6 | SM00135 | |
| Domain | LDLR_classB_rpt | 8.27e-12 | 15 | 67 | 6 | IPR000033 | |
| Domain | EGF | 2.44e-11 | 126 | 67 | 10 | PF00008 | |
| Domain | LDLR_class-A_CS | 9.40e-11 | 40 | 67 | 7 | IPR023415 | |
| Domain | Ldl_recept_a | 2.26e-10 | 45 | 67 | 7 | PF00057 | |
| Domain | - | 2.65e-10 | 46 | 67 | 7 | 4.10.400.10 | |
| Domain | LDLRA_1 | 3.63e-10 | 48 | 67 | 7 | PS01209 | |
| Domain | LDLRA_2 | 4.22e-10 | 49 | 67 | 7 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 4.22e-10 | 49 | 67 | 7 | IPR002172 | |
| Domain | LDLa | 4.22e-10 | 49 | 67 | 7 | SM00192 | |
| Domain | - | 5.04e-09 | 39 | 67 | 6 | 2.120.10.30 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.42e-08 | 46 | 67 | 6 | IPR011042 | |
| Domain | - | 4.90e-08 | 11 | 67 | 4 | 2.40.155.10 | |
| Domain | GFP-like | 4.90e-08 | 11 | 67 | 4 | IPR023413 | |
| Domain | ConA-like_dom | 1.13e-06 | 219 | 67 | 8 | IPR013320 | |
| Domain | - | 1.15e-06 | 95 | 67 | 6 | 2.60.120.200 | |
| Domain | Laminin_G | 2.02e-06 | 58 | 67 | 5 | IPR001791 | |
| Domain | cEGF | 2.13e-06 | 26 | 67 | 4 | IPR026823 | |
| Domain | cEGF | 2.13e-06 | 26 | 67 | 4 | PF12662 | |
| Domain | EGF_extracell | 2.39e-06 | 60 | 67 | 5 | IPR013111 | |
| Domain | EGF_2 | 2.39e-06 | 60 | 67 | 5 | PF07974 | |
| Domain | EGF_3 | 9.49e-06 | 12 | 67 | 3 | PF12947 | |
| Domain | EGF_dom | 9.49e-06 | 12 | 67 | 3 | IPR024731 | |
| Domain | Laminin_G_2 | 1.25e-05 | 40 | 67 | 4 | PF02210 | |
| Domain | DUF5050 | 1.27e-05 | 2 | 67 | 2 | IPR032485 | |
| Domain | MINDY_domain | 1.27e-05 | 2 | 67 | 2 | IPR033979 | |
| Domain | DUF544 | 1.27e-05 | 2 | 67 | 2 | PF04424 | |
| Domain | MINDY | 1.27e-05 | 2 | 67 | 2 | IPR007518 | |
| Domain | DUF5050 | 1.27e-05 | 2 | 67 | 2 | PF16472 | |
| Domain | LamG | 1.84e-05 | 44 | 67 | 4 | SM00282 | |
| Domain | DUF3454 | 3.79e-05 | 3 | 67 | 2 | PF11936 | |
| Domain | DUF3454_notch | 3.79e-05 | 3 | 67 | 2 | IPR024600 | |
| Domain | DUF3454 | 3.79e-05 | 3 | 67 | 2 | SM01334 | |
| Domain | Notch | 7.57e-05 | 4 | 67 | 2 | IPR008297 | |
| Domain | NODP | 7.57e-05 | 4 | 67 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 7.57e-05 | 4 | 67 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 7.57e-05 | 4 | 67 | 2 | IPR010660 | |
| Domain | NOD | 7.57e-05 | 4 | 67 | 2 | PF06816 | |
| Domain | NOD | 7.57e-05 | 4 | 67 | 2 | SM01338 | |
| Domain | NODP | 7.57e-05 | 4 | 67 | 2 | SM01339 | |
| Domain | SR | 9.59e-05 | 25 | 67 | 3 | SM00202 | |
| Domain | SRCR_1 | 1.08e-04 | 26 | 67 | 3 | PS00420 | |
| Domain | SRCR_2 | 1.08e-04 | 26 | 67 | 3 | PS50287 | |
| Domain | SRCR-like_dom | 1.08e-04 | 26 | 67 | 3 | IPR017448 | |
| Domain | SRCR | 1.21e-04 | 27 | 67 | 3 | IPR001190 | |
| Domain | LNR | 1.26e-04 | 5 | 67 | 2 | PS50258 | |
| Domain | hEGF | 1.36e-04 | 28 | 67 | 3 | PF12661 | |
| Domain | VWC | 1.36e-04 | 28 | 67 | 3 | PF00093 | |
| Domain | Notch_dom | 2.63e-04 | 7 | 67 | 2 | IPR000800 | |
| Domain | Notch | 2.63e-04 | 7 | 67 | 2 | PF00066 | |
| Domain | NL | 2.63e-04 | 7 | 67 | 2 | SM00004 | |
| Domain | VWFC_1 | 2.89e-04 | 36 | 67 | 3 | PS01208 | |
| Domain | VWC | 3.40e-04 | 38 | 67 | 3 | SM00214 | |
| Domain | VWFC_2 | 3.40e-04 | 38 | 67 | 3 | PS50184 | |
| Domain | LAM_G_DOMAIN | 3.40e-04 | 38 | 67 | 3 | PS50025 | |
| Domain | Cl-channel_core | 4.49e-04 | 9 | 67 | 2 | IPR014743 | |
| Domain | - | 4.49e-04 | 9 | 67 | 2 | 1.10.3080.10 | |
| Domain | Voltage_CLC | 4.49e-04 | 9 | 67 | 2 | PF00654 | |
| Domain | Cl-channel_volt-gated | 4.49e-04 | 9 | 67 | 2 | IPR001807 | |
| Domain | VWF_dom | 4.58e-04 | 42 | 67 | 3 | IPR001007 | |
| Domain | Laminin_G_1 | 6.83e-04 | 11 | 67 | 2 | PF00054 | |
| Domain | IBR | 1.12e-03 | 14 | 67 | 2 | SM00647 | |
| Domain | IBR | 1.12e-03 | 14 | 67 | 2 | PF01485 | |
| Domain | IBR_dom | 1.29e-03 | 15 | 67 | 2 | IPR002867 | |
| Domain | CBS | 1.47e-03 | 16 | 67 | 2 | SM00116 | |
| Domain | Znf_C2H2-like | 2.07e-03 | 796 | 67 | 9 | IPR015880 | |
| Domain | VWC_out | 2.08e-03 | 19 | 67 | 2 | SM00215 | |
| Domain | Znf_C2H2 | 2.23e-03 | 805 | 67 | 9 | IPR007087 | |
| Domain | ZnF_C2H2 | 2.29e-03 | 808 | 67 | 9 | SM00355 | |
| Domain | CBS_dom | 2.31e-03 | 20 | 67 | 2 | IPR000644 | |
| Domain | CBS | 2.31e-03 | 20 | 67 | 2 | PF00571 | |
| Domain | CBS | 2.31e-03 | 20 | 67 | 2 | PS51371 | |
| Domain | SRCR | 2.55e-03 | 21 | 67 | 2 | PF00530 | |
| Domain | zf-RanBP | 2.80e-03 | 22 | 67 | 2 | PF00641 | |
| Domain | - | 2.88e-03 | 679 | 67 | 8 | 3.30.160.60 | |
| Domain | TSPN | 3.06e-03 | 23 | 67 | 2 | SM00210 | |
| Domain | ZnF_RBZ | 3.06e-03 | 23 | 67 | 2 | SM00547 | |
| Domain | ZF_RANBP2_2 | 3.06e-03 | 23 | 67 | 2 | PS50199 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 3.29e-03 | 694 | 67 | 8 | IPR013087 | |
| Domain | ZF_RANBP2_1 | 3.33e-03 | 24 | 67 | 2 | PS01358 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | LRP12 STAB2 CD5L CLCN5 ASGR1 CD163L1 LRP1 LRP2 LRP6 LRP1B LDLR | 4.48e-08 | 381 | 48 | 11 | M48063 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.03e-05 | 13 | 48 | 3 | M47534 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.06e-05 | 48 | 48 | 4 | M27642 | |
| Pathway | KEGG_HEDGEHOG_SIGNALING_PATHWAY | 3.82e-05 | 56 | 48 | 4 | M1053 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.13e-04 | 5 | 48 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.69e-04 | 6 | 48 | 2 | M27068 | |
| Pathway | REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION | 2.36e-04 | 7 | 48 | 2 | M27501 | |
| Pathway | WP_CANCER_PATHWAYS | 2.81e-04 | 507 | 48 | 8 | M48302 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 3.65e-04 | 100 | 48 | 4 | M27158 | |
| Pathway | PID_TCPTP_PATHWAY | 3.87e-04 | 42 | 48 | 3 | M91 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP4249 | 4.16e-04 | 43 | 48 | 3 | M39706 | |
| Pathway | WP_GENES_CONTROLLING_NEPHROGENESIS | 4.45e-04 | 44 | 48 | 3 | M39891 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.76e-04 | 45 | 48 | 3 | MM15344 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 5.29e-04 | 302 | 48 | 6 | M39719 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 5.45e-04 | 198 | 48 | 5 | M18311 | |
| Pathway | WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY | 5.75e-04 | 48 | 48 | 3 | M39427 | |
| Pathway | BIOCARTA_CBL_PATHWAY | 6.12e-04 | 11 | 48 | 2 | MM1360 | |
| Pathway | REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES | 6.12e-04 | 11 | 48 | 2 | M48021 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 6.12e-04 | 11 | 48 | 2 | M47865 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 6.83e-04 | 118 | 48 | 4 | M39852 | |
| Pathway | PID_PTP1B_PATHWAY | 7.28e-04 | 52 | 48 | 3 | M50 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.33e-04 | 12 | 48 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.33e-04 | 12 | 48 | 2 | M22042 | |
| Pathway | BIOCARTA_CBL_PATHWAY | 7.33e-04 | 12 | 48 | 2 | M16973 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.33e-04 | 12 | 48 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 7.33e-04 | 12 | 48 | 2 | M47533 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 7.91e-04 | 326 | 48 | 6 | MM15917 | |
| Pathway | WP_VITAMIN_B12_METABOLISM | 8.14e-04 | 54 | 48 | 3 | M39337 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 8.65e-04 | 13 | 48 | 2 | M47423 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3 | 8.65e-04 | 13 | 48 | 2 | M42551 | |
| Pathway | KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY | 1.01e-03 | 14 | 48 | 2 | M47414 | |
| Pathway | WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM | 1.11e-03 | 60 | 48 | 3 | M40048 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5 | 1.16e-03 | 15 | 48 | 2 | M42552 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 1.16e-03 | 15 | 48 | 2 | MM1498 | |
| Pathway | WP_HEDGEHOG_SIGNALING_WP47 | 1.32e-03 | 16 | 48 | 2 | M39675 | |
| Pathway | BIOCARTA_SHH_PATHWAY | 1.32e-03 | 16 | 48 | 2 | M11792 | |
| Pathway | WP_MALE_INFERTILITY | 1.47e-03 | 145 | 48 | 4 | M39856 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.59e-03 | 68 | 48 | 3 | M27303 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.68e-03 | 18 | 48 | 2 | M614 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1 | 1.68e-03 | 18 | 48 | 2 | M42559 | |
| Pathway | WP_BREAST_CANCER_PATHWAY | 1.83e-03 | 154 | 48 | 4 | M39739 | |
| Pathway | WP_STATIN_PATHWAY | 1.87e-03 | 19 | 48 | 2 | MM15868 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.87e-03 | 72 | 48 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.95e-03 | 73 | 48 | 3 | MM15906 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 2.07e-03 | 20 | 48 | 2 | M27881 | |
| Pathway | WP_HEDGEHOG_SIGNALING_PATHWAY | 2.51e-03 | 22 | 48 | 2 | MM15924 | |
| Pathway | WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4 | 2.51e-03 | 22 | 48 | 2 | M42574 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.72e-03 | 82 | 48 | 3 | MM15922 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 2.81e-03 | 83 | 48 | 3 | M47961 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.99e-03 | 24 | 48 | 2 | M11190 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL | 3.24e-03 | 25 | 48 | 2 | M47934 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 5.67e-10 | 21 | 70 | 5 | 21337463 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 1.46e-09 | 101 | 70 | 7 | 23382219 | |
| Pubmed | 4.91e-09 | 11 | 70 | 4 | 24639464 | ||
| Pubmed | 7.81e-09 | 3 | 70 | 3 | 3066742 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 1.48e-08 | 14 | 70 | 4 | 17389516 | |
| Pubmed | 3.12e-08 | 4 | 70 | 3 | 7775583 | ||
| Pubmed | 7.79e-08 | 5 | 70 | 3 | 18685438 | ||
| Pubmed | 1.47e-07 | 118 | 70 | 6 | 21078624 | ||
| Pubmed | 1.55e-07 | 6 | 70 | 3 | 9837937 | ||
| Pubmed | Physical and functional interactions between Zic and Gli proteins. | 1.55e-07 | 6 | 70 | 3 | 11238441 | |
| Pubmed | 2.72e-07 | 7 | 70 | 3 | 12169628 | ||
| Pubmed | CD spectra show the relational style between Zic-, Gli-, Glis-zinc finger protein and DNA. | 9.28e-07 | 10 | 70 | 3 | 18298960 | |
| Pubmed | 9.28e-07 | 10 | 70 | 3 | 15736266 | ||
| Pubmed | Isolation and Characterization of Fetal Leydig Progenitor Cells of Male Mice. | 9.45e-07 | 37 | 70 | 4 | 26697723 | |
| Pubmed | 2.20e-06 | 13 | 70 | 3 | 34887903 | ||
| Pubmed | Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. | 2.20e-06 | 13 | 70 | 3 | 16207730 | |
| Pubmed | 2.80e-06 | 14 | 70 | 3 | 15082773 | ||
| Pubmed | 3.15e-06 | 199 | 70 | 6 | 23382691 | ||
| Pubmed | 3.49e-06 | 15 | 70 | 3 | 22340494 | ||
| Pubmed | 3.62e-06 | 608 | 70 | 9 | 16713569 | ||
| Pubmed | A role for the apoptosis inhibitory factor AIM/Spalpha/Api6 in atherosclerosis development. | 3.99e-06 | 2 | 70 | 2 | 16054063 | |
| Pubmed | Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. | 3.99e-06 | 2 | 70 | 2 | 19273907 | |
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 3.99e-06 | 2 | 70 | 2 | 24508387 | |
| Pubmed | Striking differences of LDL receptor-related protein 1B expression in mouse and human. | 3.99e-06 | 2 | 70 | 2 | 15963947 | |
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 3.99e-06 | 2 | 70 | 2 | 23380742 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 18559511 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22665268 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17889283 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21466361 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 20069650 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15625786 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 12351188 | ||
| Pubmed | A three-part signal governs differential processing of Gli1 and Gli3 proteins by the proteasome. | 3.99e-06 | 2 | 70 | 2 | 21921029 | |
| Pubmed | Upregulation of hepatic LDL transport by n-3 fatty acids in LDL receptor knockout mice. | 3.99e-06 | 2 | 70 | 2 | 11971949 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16129671 | ||
| Pubmed | Hierarchy of Notch-Delta interactions promoting T cell lineage commitment and maturation. | 3.99e-06 | 2 | 70 | 2 | 17261636 | |
| Pubmed | Motch A and motch B--two mouse Notch homologues coexpressed in a wide variety of tissues. | 3.99e-06 | 2 | 70 | 2 | 8440332 | |
| Pubmed | Palmar and plantar pads and flexion creases of genetic polydactyly mice (Pdn). | 3.99e-06 | 2 | 70 | 2 | 9918099 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 14991768 | ||
| Pubmed | Differential expression of Notch1 and Notch2 in developing and adult mouse brain. | 3.99e-06 | 2 | 70 | 2 | 7609614 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 33017398 | ||
| Pubmed | LRP: role in vascular wall integrity and protection from atherosclerosis. | 3.99e-06 | 2 | 70 | 2 | 12690199 | |
| Pubmed | Notch2 governs the rate of generation of mouse long- and short-term repopulating stem cells. | 3.99e-06 | 2 | 70 | 2 | 21285514 | |
| Pubmed | Both Notch1 and Notch2 contribute to the regulation of melanocyte homeostasis. | 3.99e-06 | 2 | 70 | 2 | 18353145 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 22205705 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21661123 | ||
| Pubmed | Notch signaling induces cell cycle arrest in small cell lung cancer cells. | 3.99e-06 | 2 | 70 | 2 | 11306509 | |
| Pubmed | The association between insulin and low-density lipoprotein receptors. | 3.99e-06 | 2 | 70 | 2 | 22278734 | |
| Pubmed | Correlation of asymmetric Notch2 expression and mouse incisor rotation. | 3.99e-06 | 2 | 70 | 2 | 10704869 | |
| Pubmed | Notch signaling is necessary but not sufficient for differentiation of dendritic cells. | 3.99e-06 | 2 | 70 | 2 | 12907456 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25723053 | ||
| Pubmed | Gli3 is a Key Factor in the Schwann Cells from Both Intact and Injured Peripheral Nerves. | 3.99e-06 | 2 | 70 | 2 | 32114096 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 23589286 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10693759 | ||
| Pubmed | NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes. | 3.99e-06 | 2 | 70 | 2 | 24109236 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 8917536 | ||
| Pubmed | Functional conservation of Notch1 and Notch2 intracellular domains. | 3.99e-06 | 2 | 70 | 2 | 15897231 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17369355 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 30296524 | ||
| Pubmed | Notch1 but not Notch2 is essential for generating hematopoietic stem cells from endothelial cells. | 3.99e-06 | 2 | 70 | 2 | 12753746 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 26041884 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 9045712 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 15492845 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 29643502 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17154366 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 9449704 | ||
| Pubmed | The combined hyperlipidemia caused by impaired Wnt-LRP6 signaling is reversed by Wnt3a rescue. | 3.99e-06 | 2 | 70 | 2 | 24506864 | |
| Pubmed | gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. | 3.99e-06 | 2 | 70 | 2 | 8364225 | |
| Pubmed | Notch Inhibition Prevents Differentiation of Human Limbal Stem/Progenitor Cells in vitro. | 3.99e-06 | 2 | 70 | 2 | 31316119 | |
| Pubmed | Chloride/proton antiporter activity of mammalian CLC proteins ClC-4 and ClC-5. | 3.99e-06 | 2 | 70 | 2 | 16034421 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 24877199 | ||
| Pubmed | A role for notch signaling in human corneal epithelial cell differentiation and proliferation. | 3.99e-06 | 2 | 70 | 2 | 17652726 | |
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 3.99e-06 | 2 | 70 | 2 | 26031789 | |
| Pubmed | Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. | 3.99e-06 | 2 | 70 | 2 | 25041344 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17505534 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34445520 | ||
| Pubmed | Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. | 3.99e-06 | 2 | 70 | 2 | 25866967 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 32423029 | ||
| Pubmed | Notch2 signaling is required for potent antitumor immunity in vivo. | 3.99e-06 | 2 | 70 | 2 | 20351182 | |
| Pubmed | LRP6 protein regulates low density lipoprotein (LDL) receptor-mediated LDL uptake. | 3.99e-06 | 2 | 70 | 2 | 22128165 | |
| Pubmed | Involvement of Notch in activation and effector functions of γδ T cells. | 3.99e-06 | 2 | 70 | 2 | 24489102 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 16581003 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25103784 | ||
| Pubmed | The Notch pathway in podocytes plays a role in the development of glomerular disease. | 3.99e-06 | 2 | 70 | 2 | 18311147 | |
| Pubmed | Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. | 3.99e-06 | 2 | 70 | 2 | 25141821 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25393517 | ||
| Pubmed | Notch1 and Notch2 receptors regulate mouse and human gastric antral epithelial cell homoeostasis. | 3.99e-06 | 2 | 70 | 2 | 26933171 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 21693515 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 27023845 | ||
| Pubmed | Notch signalling suppresses regulatory T-cell function in murine experimental autoimmune uveitis. | 3.99e-06 | 2 | 70 | 2 | 27564686 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 25982147 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19701457 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 10575007 | ||
| Pubmed | Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. | 3.99e-06 | 2 | 70 | 2 | 28820917 | |
| Pubmed | Loss-of-function mutations in Notch receptors in cutaneous and lung squamous cell carcinoma. | 3.99e-06 | 2 | 70 | 2 | 22006338 | |
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19339697 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 19915064 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 17709443 | ||
| Pubmed | 3.99e-06 | 2 | 70 | 2 | 34227185 | ||
| Pubmed | Programs for the persistence, vigilance and control of human CD8+ lung-resident memory T cells. | 3.99e-06 | 2 | 70 | 2 | 27776108 | |
| Interaction | IGFL3 interactions | 1.75e-10 | 75 | 69 | 8 | int:IGFL3 | |
| Interaction | WNT3A interactions | 1.61e-08 | 49 | 69 | 6 | int:WNT3A | |
| Interaction | FOXD4L6 interactions | 1.61e-08 | 49 | 69 | 6 | int:FOXD4L6 | |
| Interaction | NTN5 interactions | 1.64e-08 | 24 | 69 | 5 | int:NTN5 | |
| Interaction | CCN6 interactions | 4.69e-07 | 19 | 69 | 4 | int:CCN6 | |
| Interaction | TIMP3 interactions | 6.41e-07 | 90 | 69 | 6 | int:TIMP3 | |
| Interaction | ZNF408 interactions | 6.41e-07 | 145 | 69 | 7 | int:ZNF408 | |
| Interaction | MDK interactions | 6.84e-07 | 91 | 69 | 6 | int:MDK | |
| Interaction | EGFL6 interactions | 7.21e-07 | 21 | 69 | 4 | int:EGFL6 | |
| Interaction | ZFP41 interactions | 1.48e-06 | 57 | 69 | 5 | int:ZFP41 | |
| Interaction | PLAT interactions | 2.45e-06 | 63 | 69 | 5 | int:PLAT | |
| Interaction | TAFA3 interactions | 7.06e-06 | 78 | 69 | 5 | int:TAFA3 | |
| Interaction | LRP1B interactions | 1.08e-05 | 85 | 69 | 5 | int:LRP1B | |
| Interaction | ZNF768 interactions | 1.30e-05 | 151 | 69 | 6 | int:ZNF768 | |
| Interaction | IGSF5 interactions | 1.36e-05 | 14 | 69 | 3 | int:IGSF5 | |
| Interaction | DKK2 interactions | 2.37e-05 | 49 | 69 | 4 | int:DKK2 | |
| Interaction | MAML3 interactions | 4.20e-05 | 20 | 69 | 3 | int:MAML3 | |
| Interaction | ATN1 interactions | 4.35e-05 | 187 | 69 | 6 | int:ATN1 | |
| Interaction | CACNA1A interactions | 6.42e-05 | 123 | 69 | 5 | int:CACNA1A | |
| Interaction | GLI4 interactions | 6.93e-05 | 125 | 69 | 5 | int:GLI4 | |
| Interaction | ZSCAN21 interactions | 7.76e-05 | 128 | 69 | 5 | int:ZSCAN21 | |
| Interaction | DYRK1A interactions | 1.07e-04 | 552 | 69 | 9 | int:DYRK1A | |
| Interaction | EGFL7 interactions | 1.41e-04 | 77 | 69 | 4 | int:EGFL7 | |
| Interaction | NMS interactions | 1.46e-04 | 30 | 69 | 3 | int:NMS | |
| Interaction | SNX17 interactions | 1.72e-04 | 81 | 69 | 4 | int:SNX17 | |
| Interaction | LRP2 interactions | 1.85e-04 | 154 | 69 | 5 | int:LRP2 | |
| Interaction | ANKS1B interactions | 2.13e-04 | 34 | 69 | 3 | int:ANKS1B | |
| Interaction | LTBP3 interactions | 2.32e-04 | 35 | 69 | 3 | int:LTBP3 | |
| Interaction | DLK2 interactions | 2.53e-04 | 36 | 69 | 3 | int:DLK2 | |
| Interaction | WNT10A interactions | 2.75e-04 | 37 | 69 | 3 | int:WNT10A | |
| Interaction | TMEFF1 interactions | 2.75e-04 | 37 | 69 | 3 | int:TMEFF1 | |
| Interaction | GREM2 interactions | 2.75e-04 | 37 | 69 | 3 | int:GREM2 | |
| Interaction | LDLRAP1 interactions | 2.75e-04 | 37 | 69 | 3 | int:LDLRAP1 | |
| Interaction | CTSG interactions | 3.17e-04 | 95 | 69 | 4 | int:CTSG | |
| Interaction | ZIC2 interactions | 3.21e-04 | 39 | 69 | 3 | int:ZIC2 | |
| Interaction | JAG1 interactions | 3.73e-04 | 41 | 69 | 3 | int:JAG1 | |
| Interaction | LRPAP1 interactions | 3.81e-04 | 180 | 69 | 5 | int:LRPAP1 | |
| Interaction | ZNF415 interactions | 4.10e-04 | 9 | 69 | 2 | int:ZNF415 | |
| GeneFamily | Low density lipoprotein receptors | 6.28e-13 | 13 | 51 | 6 | 634 | |
| GeneFamily | Fibulins | 2.16e-04 | 8 | 51 | 2 | 556 | |
| GeneFamily | Chloride voltage-gated channels | 3.46e-04 | 10 | 51 | 2 | 302 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 8.35e-04 | 718 | 51 | 8 | 28 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.58e-03 | 21 | 51 | 2 | 89 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 2.62e-03 | 27 | 51 | 2 | 1253 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 5.68e-03 | 40 | 51 | 2 | 321 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.38e-08 | 196 | 70 | 8 | M3008 | |
| Coexpression | TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL | 6.21e-07 | 270 | 70 | 8 | M41699 | |
| Coexpression | NABA_CORE_MATRISOME | 7.13e-07 | 275 | 70 | 8 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 7.95e-07 | 191 | 70 | 7 | MM17059 | |
| Coexpression | NABA_CORE_MATRISOME | 7.85e-06 | 270 | 70 | 7 | MM17057 | |
| Coexpression | NABA_MATRISOME | NELL1 THBS1 EYS EFEMP1 HMCN2 EGF CRIM1 WFIKKN2 LAMA1 FGL1 LGALS2 EGFL6 | 1.59e-05 | 1026 | 70 | 12 | M5889 |
| Coexpression | LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB | 2.69e-05 | 131 | 70 | 5 | M39232 | |
| Coexpression | NABA_MATRISOME | NELL1 THBS1 EFEMP1 HMCN2 EGF CRIM1 WFIKKN2 LAMA1 FGL1 LGALS2 EGFL6 | 6.98e-05 | 1008 | 70 | 11 | MM17056 |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#2_top-relative-expression-ranked_200 | 3.89e-06 | 33 | 69 | 4 | gudmap_kidney_adult_RenalCortexMixed_Std_k2_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_100 | 4.95e-06 | 35 | 69 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k4_100 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#4_top-relative-expression-ranked_200 | 1.04e-05 | 42 | 69 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k4_200 | |
| CoexpressionAtlas | kidney_adult_RenalCortexMixed_Std_k-means-cluster#1_top-relative-expression-ranked_100 | 1.78e-05 | 16 | 69 | 3 | gudmap_kidney_adult_RenalCortexMixed_Std_k1_100 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | CLCN5 CRIM1 GLI3 ZNF566 LAMA1 LRP2 PELI2 CORIN NOTCH1 NOTCH2 EGFL6 | 4.14e-05 | 783 | 69 | 11 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_Captopr_k-means-cluster#1_top-relative-expression-ranked_100 | 7.18e-05 | 25 | 69 | 3 | gudmap_kidney_adult_JuxtaGlom_Ren1_Captopr_k1_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 8.42e-05 | 437 | 69 | 8 | GSM605865_500 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_k-means-cluster#1_top-relative-expression-ranked_200 | 1.10e-04 | 76 | 69 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_k1_200 | |
| CoexpressionAtlas | kidney_adult_JuxtaGlom_Ren1_top-relative-expression-ranked_100 | 1.34e-04 | 80 | 69 | 4 | gudmap_kidney_adult_JuxtaGlom_Ren1_100 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | THBS1 EFEMP1 CRIM1 INSR LAMA1 LRP2 UMOD CORIN SLC5A12 MINDY2 NOTCH2 | 1.50e-04 | 905 | 69 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | BM Top 100 - kidney cortex | 1.55e-04 | 83 | 69 | 4 | BM Top 100 - kidney cortex | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480hi.PC, CD115+ MHC II- F480hi Siglec F-, Peritoneal Cavity, avg-3 | 1.62e-04 | 84 | 69 | 4 | GSM605862_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.77e-04 | 86 | 69 | 4 | GSM605850_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_500 | 2.01e-04 | 496 | 69 | 8 | PCBC_EB_blastocyst_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_500 | 2.04e-04 | 497 | 69 | 8 | PCBC_EB_fibroblast_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_fromBlastocyst-derived-humanEmbryonicStemCells_top-relative-expression-ranked_1000 | NELL1 HMCN2 LMX1B KIF26B LAMA1 LRP2 SLC5A12 FGL1 LRP1B LGALS2 EGFL6 | 3.32e-04 | 992 | 69 | 11 | PCBC_EB_blastocyst_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.44e-04 | 42 | 69 | 3 | gudmap_kidney_adult_Podocyte_MafB_k4_500 | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 8.77e-10 | 197 | 70 | 8 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.45e-08 | 195 | 70 | 7 | 403d874198a7bde626b0d0b4efad8dbb34060761 | |
| ToppCell | (7)_Monocyte|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.54e-08 | 196 | 70 | 7 | 0232167559dcd2d86ee8b78017cf5f2a084b2cb7 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.54e-08 | 196 | 70 | 7 | f943519bff51c3094776fd45889dadf9062c8379 | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.63e-08 | 197 | 70 | 7 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | (4)_Monocyte|World / shred on Cell_type and subtype | 2.73e-08 | 198 | 70 | 7 | 56f9ebf902fe81c590696ba4c88028deaf346841 | |
| ToppCell | Transverse-Macrophage-Macrophage|Transverse / Region, Cell class and subclass | 2.92e-08 | 200 | 70 | 7 | 17548806ba38008050244151d1216c69ef8a8310 | |
| ToppCell | Transverse-(6)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 2.92e-08 | 200 | 70 | 7 | b28350de555fa756d2631f004f71d5ac69b1affe | |
| ToppCell | Caecum-(4)_Monocyte-(40)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 2.92e-08 | 200 | 70 | 7 | b078058efc51f0ff4d92123b712933b32824c655 | |
| ToppCell | Caecum-(4)_Monocyte|Caecum / shred on region, Cell_type, and subtype | 2.92e-08 | 200 | 70 | 7 | 6bfd6ab395e09087aeedc9a7c9ada1b4b8a26194 | |
| ToppCell | Caecum-Monocyte|Caecum / Region, Cell class and subclass | 2.92e-08 | 200 | 70 | 7 | 9e8d38d024a315512521b349e8ac7caa56219daf | |
| ToppCell | Transverse-Macrophage|Transverse / Region, Cell class and subclass | 2.92e-08 | 200 | 70 | 7 | 1920605e5811938814d02b971069a4506868db5f | |
| ToppCell | Biopsy_Control_(H.)-Immune-Monocytes|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.92e-08 | 200 | 70 | 7 | c58a5dc0a0d74a21ca15ee8b7a0197de32afa045 | |
| ToppCell | Caecum-Monocyte-Monocyte|Caecum / Region, Cell class and subclass | 2.92e-08 | 200 | 70 | 7 | d33619b6c721eae3ebe50fba6b9d31fa99f2248f | |
| ToppCell | Transverse-(6)_Macrophage-(60)_Macrophage|Transverse / shred on region, Cell_type, and subtype | 2.92e-08 | 200 | 70 | 7 | 2be675684a2958ea609939bb45248bede78a26bc | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 3.34e-08 | 204 | 70 | 7 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | (40)_Monocyte|World / shred on Cell_type and subtype | 3.58e-08 | 206 | 70 | 7 | d78a70f951265ef6df8f64404107be4f53e75d28 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.39e-07 | 175 | 70 | 6 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.75e-07 | 178 | 70 | 6 | cda7695411655bd6d0ba69e5041ca7530a9dad3a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-07 | 180 | 70 | 6 | eee71184ebed2694d3e60f579a44b3cf7dd2cd35 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-07 | 180 | 70 | 6 | a17dbe03597b81e7a1fe2bf2d23e59e55c615a2a | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.27e-07 | 182 | 70 | 6 | 041bc819e6cf2618bf86bce8dfe2df673f392ba3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.41e-07 | 183 | 70 | 6 | 31ab55d5f3639f5964541d5eae23044dbda3356e | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-07 | 184 | 70 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.55e-07 | 184 | 70 | 6 | 235890e8b424f4386b6ea52d173d20a00898df73 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-07 | 184 | 70 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-07 | 184 | 70 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.70e-07 | 185 | 70 | 6 | 898a093757f86be3e18d2ef1f16a71f50ef81dc3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.85e-07 | 186 | 70 | 6 | 73cf266aeecd3cc15e8cb6094588a393bca8fbe6 | |
| ToppCell | 10x5'-GI_small-bowel-Myeloid_Monocytic-Nonclassical_monocytes|GI_small-bowel / Manually curated celltypes from each tissue | 4.85e-07 | 186 | 70 | 6 | a16ecf70271894a842925f232009e2623d16947e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-07 | 187 | 70 | 6 | 85e58a312fc325e4063a2d250666b99b8f99beb6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.00e-07 | 187 | 70 | 6 | b93cf4dfe8ffb89348ee7bccc9f284189f7240a2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-07 | 189 | 70 | 6 | f51cdc9a47371cab8ed9ae63a6f14da07ede446c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.32e-07 | 189 | 70 | 6 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-07 | 190 | 70 | 6 | 78cc6c28b31de041c24175a98f47da256ecc15a2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-07 | 190 | 70 | 6 | b94df372bc08de11585b2467dba8c8fffff5cd92 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Non-neuronal-Macroglial-Astro-Astrocyte|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.49e-07 | 190 | 70 | 6 | e67d9400467b438592690b23d681e6c2fb8f09fd | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.49e-07 | 190 | 70 | 6 | 3dcadabbefe0128a5f30ab51234f049ab4d870c6 | |
| ToppCell | COVID-19-kidney-TAL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.66e-07 | 191 | 70 | 6 | fe55475ce0666ab5122447a813dc2369e24947b8 | |
| ToppCell | COVID-19-kidney-Mito-rich_Distal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.66e-07 | 191 | 70 | 6 | 0965f621ebcd92ccdeb21cc27022180ce3cfe910 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.84e-07 | 192 | 70 | 6 | 562df5e87038c500dd3a003fe5374cb31946b145 | |
| ToppCell | MS-granulo1-|MS / Condition, Cell_class and T cell subcluster | 6.39e-07 | 195 | 70 | 6 | eeaa2ecbcfbfb203c77261367b43ce55e786b312 | |
| ToppCell | MS-granulo1|MS / Condition, Cell_class and T cell subcluster | 6.39e-07 | 195 | 70 | 6 | 29688f55a6cdefbff4e818c20cb89473fbc16a59 | |
| ToppCell | (7)_Macrophage|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.58e-07 | 196 | 70 | 6 | f1c822860d2a0bae84b0263b0151185756423e0f | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.78e-07 | 197 | 70 | 6 | a1d42d0177630e08f36a96a6272f796244c1a319 | |
| ToppCell | PBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 6.78e-07 | 197 | 70 | 6 | bb0d814d88a14199eb8ab2b3bd67511b19e3ab5d | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.78e-07 | 197 | 70 | 6 | f431f11196dc4332933b5d71c7c7408d54c2dedc | |
| ToppCell | myeloid-Monocyte-CD14+_Monocyte|World / Lineage, cell class and subclass | 6.98e-07 | 198 | 70 | 6 | 2528062d1646746b2e7d6b0ec38f8cfabf3df18f | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.98e-07 | 198 | 70 | 6 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | Multiple_Sclerosis-Myeloid|Multiple_Sclerosis / Disease, Lineage and Cell Type | 6.98e-07 | 198 | 70 | 6 | 3c2817d95011ae372d0316ccf774e975536207b0 | |
| ToppCell | myeloid|World / Lineage, cell class and subclass | 6.98e-07 | 198 | 70 | 6 | 67334ca0ec4a5070d8ddaecffb84e7437bf77765 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 6.98e-07 | 198 | 70 | 6 | 187a04d498f0b355cb11c81172721698818082d6 | |
| ToppCell | myeloid-Monocyte|World / Lineage, cell class and subclass | 6.98e-07 | 198 | 70 | 6 | ab60faa27ab1f6c510154311d9658d770189f17b | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic|Liver / Manually curated celltypes from each tissue | 6.98e-07 | 198 | 70 | 6 | d0925948bf667545fb0b343e2fc80f7379e433e3 | |
| ToppCell | 10x5'-blood-Myeloid_Monocytic|blood / Manually curated celltypes from each tissue | 6.98e-07 | 198 | 70 | 6 | c0985fff359c78d0fc1b6f31885aa168c9f5fdae | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.98e-07 | 198 | 70 | 6 | 065c8a9655d19f93dfdb453c78bbfe7d857caf3e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.19e-07 | 199 | 70 | 6 | 4fc03377c017209111561789226621d258291481 | |
| ToppCell | Healthy_donor-Classical_Monocyte|World / disease group, cell group and cell class (v2) | 7.19e-07 | 199 | 70 | 6 | 45e9099a13becb1e235435ceaaffb92b82ce34ee | |
| ToppCell | distal-2-Hematologic-Intermediate_Monocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.19e-07 | 199 | 70 | 6 | 5e209df67cfe8ac7437cc363f1c5c3166bfae1af | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.19e-07 | 199 | 70 | 6 | 7dde5c02fcae64cd2d68f607500f2a46b97851fd | |
| ToppCell | 10x5'-bone_marrow-Myeloid_Monocytic|bone_marrow / Manually curated celltypes from each tissue | 7.19e-07 | 199 | 70 | 6 | 62b0861faf173eead75678aad10d396cd0d80c2c | |
| ToppCell | Healthy/Control-Classical_Monocyte|World / Disease group and Cell class | 7.19e-07 | 199 | 70 | 6 | 527c767a09f911e319f7ad230b6518cebc0f367d | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic-Classical_monocytes|Liver / Manually curated celltypes from each tissue | 7.19e-07 | 199 | 70 | 6 | 46491e8e76aa4d7ada036946f93cf71609c85462 | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.19e-07 | 199 | 70 | 6 | f393f8d2b9711e71beb4f1c5e7cac5acb047fd0e | |
| ToppCell | 356C-Myeloid|356C / Donor, Lineage, Cell class and subclass (all cells) | 7.19e-07 | 199 | 70 | 6 | aca97ade3e4cc528315fa327e74a6245300f7b8c | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.19e-07 | 199 | 70 | 6 | 84879280851380e5bfe6bd48b6bbf57aedf6e003 | |
| ToppCell | distal-Hematologic-Intermediate_Monocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 7.19e-07 | 199 | 70 | 6 | fa362f3e456a4853652e52d54e76473809eea76d | |
| ToppCell | Transverse-(4)_Monocyte|Transverse / shred on region, Cell_type, and subtype | 7.41e-07 | 200 | 70 | 6 | 85714e8da539366b5bce071dfea8f8055de527bc | |
| ToppCell | Transverse-Monocyte-Monocyte|Transverse / Region, Cell class and subclass | 7.41e-07 | 200 | 70 | 6 | 96ecfab57e998134e164b4a62881ef6f2612bd8d | |
| ToppCell | Sigmoid-Macrophage-Macrophage|Sigmoid / Region, Cell class and subclass | 7.41e-07 | 200 | 70 | 6 | 9ee3a799de7bade1bfe94b6827461633f02bc1dc | |
| ToppCell | Transverse-Monocyte|Transverse / Region, Cell class and subclass | 7.41e-07 | 200 | 70 | 6 | d70aeb57b98496474b97906505576640fdbdf34c | |
| ToppCell | mLN-Macrophage|mLN / Region, Cell class and subclass | 7.41e-07 | 200 | 70 | 6 | 68d709afd226241e002dae6d6820bccd1cfd87a1 | |
| ToppCell | mLN-(6)_Macrophage|mLN / shred on region, Cell_type, and subtype | 7.41e-07 | 200 | 70 | 6 | 6dcba82a7d322102bae205543086e84c7655b3e0 | |
| ToppCell | Sigmoid-(6)_Macrophage-(60)_Macrophage|Sigmoid / shred on region, Cell_type, and subtype | 7.41e-07 | 200 | 70 | 6 | ad84a83a5a1893f7b053d39eddeca851463a8ff0 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Monocytic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 7.41e-07 | 200 | 70 | 6 | 1003f0f417b015f0fe8ff71dd47449de22214d62 | |
| ToppCell | Bronchial-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.41e-07 | 200 | 70 | 6 | d237cf947d6768b022d18211e14af4adb4990708 | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid|Multiple_Sclerosis / Disease, condition lineage and cell class | 7.41e-07 | 200 | 70 | 6 | 69e4727dda76aa13c4e95f10b9b217c3cd7478d8 | |
| ToppCell | Transverse-(4)_Monocyte-(40)_Monocyte|Transverse / shred on region, Cell_type, and subtype | 7.41e-07 | 200 | 70 | 6 | 0187a4b1d2c3c89b7769d632e6d88190a06b093e | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.41e-07 | 200 | 70 | 6 | 0855ebb10b925664aa5cf813d97e97683c46180d | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 7.41e-07 | 200 | 70 | 6 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | (61)_LYVE1_Macrophage|World / shred on Cell_type and subtype | 8.80e-07 | 206 | 70 | 6 | 711e961a9a03bfd2f0958bd14f25f7f207a2f2b5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.70e-06 | 139 | 70 | 5 | a1945b07f177cde40e7eea03a19236ce76165857 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.31e-06 | 153 | 70 | 5 | 0307f10e772021ae68a42690634df458672a6df9 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 160 | 70 | 5 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.87e-06 | 163 | 70 | 5 | cab65dabeea58141c649e4fec5e0123beb3de1b3 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.80e-06 | 168 | 70 | 5 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.80e-06 | 168 | 70 | 5 | 9930bd63b60c03f0152838a79eef77da1c2dd8e5 | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-nan|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.63e-06 | 172 | 70 | 5 | 5f18c3f8eb8b7928901eede44c9b84b3c5efa1a9 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 7.84e-06 | 173 | 70 | 5 | 38f88f5bbf92a3bf5109bc4782cd071b7cb1ca34 | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.29e-06 | 175 | 70 | 5 | c9dc6aa652ac887470806a950311657c423d9495 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-06 | 178 | 70 | 5 | dfed0fbf7a73b8a9e00178ec58dc4592b271c344 | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Myeloid-macrophage|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.00e-06 | 178 | 70 | 5 | 6c1b5087581ca8cea976d89ea6f34088c8fc3668 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.00e-06 | 178 | 70 | 5 | 4df6218b20c2f076c22346d23260964cc0d73e65 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-06 | 179 | 70 | 5 | d0fa700648db8ce76a8aa689879a25048299fa40 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.25e-06 | 179 | 70 | 5 | 2e49b215b71438400aebb483f2c2c08d5e956961 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 180 | 70 | 5 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 1.06e-05 | 184 | 70 | 5 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.06e-05 | 184 | 70 | 5 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.09e-05 | 185 | 70 | 5 | 03f64a7132b13a01ba47187e0e15c13ac88f7cb2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 186 | 70 | 5 | 1850583d23903d08226aeb0edb3e07b0994330e4 | |
| Computational | Metal / Ca ion binding. | 2.21e-04 | 133 | 45 | 5 | MODULE_324 | |
| Drug | monatepil | 2.79e-10 | 29 | 69 | 6 | CID000060810 | |
| Drug | 25-hydroxycholesterol | 2.90e-08 | 160 | 69 | 8 | CID000065094 | |
| Drug | pitavastatin | 1.28e-06 | 114 | 69 | 6 | CID005282451 | |
| Drug | ezetimibe | 5.61e-06 | 147 | 69 | 6 | CID000150311 | |
| Drug | AC1L1J6H | 7.35e-06 | 236 | 69 | 7 | CID000004889 | |
| Drug | Epi Lovastatin | 8.81e-06 | 341 | 69 | 8 | CID000003962 | |
| Drug | sodium linoleate | 9.00e-06 | 342 | 69 | 8 | CID000003931 | |
| Drug | probucol | 9.79e-06 | 162 | 69 | 6 | CID000004912 | |
| Drug | mangrove | 1.15e-05 | 468 | 69 | 9 | CID000000965 | |
| Drug | Calpain inhibitor I | 2.22e-05 | 280 | 69 | 7 | CID000004332 | |
| Drug | Ketanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; PC3; HT_HG-U133A | 2.35e-05 | 189 | 69 | 6 | 6649_DN | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; PC3; HT_HG-U133A | 2.64e-05 | 193 | 69 | 6 | 6613_DN | |
| Drug | Tropicamide [1508-75-4]; Up 200; 14uM; MCF7; HT_HG-U133A | 2.72e-05 | 194 | 69 | 6 | 4744_UP | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.88e-05 | 196 | 69 | 6 | 5249_DN | |
| Drug | Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 2.88e-05 | 196 | 69 | 6 | 7187_DN | |
| Drug | Fluoxetine hydrochloride [59333-67-4]; Down 200; 11.6uM; PC3; HT_HG-U133A | 2.88e-05 | 196 | 69 | 6 | 6757_DN | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.88e-05 | 196 | 69 | 6 | 6338_UP | |
| Drug | troglitazone | 2.90e-05 | 526 | 69 | 9 | CID000005591 | |
| Drug | Quinethazone [73-49-4]; Up 200; 13.8uM; PC3; HT_HG-U133A | 3.05e-05 | 198 | 69 | 6 | 4529_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; PC3; HT_HG-U133A | 3.05e-05 | 198 | 69 | 6 | 3745_DN | |
| Drug | Dibucaine [85-79-0]; Down 200; 11.6uM; PC3; HT_HG-U133A | 3.14e-05 | 199 | 69 | 6 | 4068_DN | |
| Drug | Metrizamide [31112-62-6]; Down 200; 5uM; PC3; HT_HG-U133A | 3.22e-05 | 200 | 69 | 6 | 4075_DN | |
| Drug | GBR 12909 dihydrochloride [67469-78-7]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.22e-05 | 200 | 69 | 6 | 3240_DN | |
| Drug | iodide | 3.26e-05 | 534 | 69 | 9 | CID000024841 | |
| Drug | sunitinib | 4.71e-05 | 130 | 69 | 5 | CID005329102 | |
| Drug | O148 | 5.41e-05 | 4 | 69 | 2 | CID000078219 | |
| Drug | 2-naphthylbenzothiazole | 5.41e-05 | 4 | 69 | 2 | CID011585872 | |
| Drug | N,N-dibenzylphenylethanolamine | 5.41e-05 | 4 | 69 | 2 | CID000048896 | |
| Drug | 1w1p | 5.84e-05 | 25 | 69 | 3 | CID000126154 | |
| Drug | isocycloheximide | 8.15e-05 | 905 | 69 | 11 | CID000002900 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 9.20e-05 | 29 | 69 | 3 | CID000167918 | |
| Drug | steviol | 1.02e-04 | 30 | 69 | 3 | ctd:C012042 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 1.08e-04 | 155 | 69 | 5 | 6817_DN | |
| Drug | Dietary Sucrose | NELL1 CSF1R LRRC25 ACACA GLI1 GLI3 DGKK DNAH17 LAMA1 UMOD ZIC2 | 1.16e-04 | 942 | 69 | 11 | ctd:D019422 |
| Drug | 2,6-diethylaniline | 1.24e-04 | 32 | 69 | 3 | CID000011369 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 1.26e-04 | 160 | 69 | 5 | 6133_DN | |
| Drug | pendolmycin | 1.35e-04 | 6 | 69 | 2 | CID000154206 | |
| Drug | simvastatin | 1.78e-04 | 390 | 69 | 7 | CID000054454 | |
| Drug | 2-phenylbenzothiazole | 1.88e-04 | 7 | 69 | 2 | CID000013439 | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 1.91e-04 | 175 | 69 | 5 | 2485_UP | |
| Drug | Reidispongiolide C | 2.01e-04 | 279 | 69 | 6 | CID005289285 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.02e-04 | 177 | 69 | 5 | 4652_DN | |
| Drug | butenal | 2.18e-04 | 180 | 69 | 5 | CID000020138 | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.18e-04 | 180 | 69 | 5 | 7356_UP | |
| Drug | sodium cholate | 2.34e-04 | 408 | 69 | 7 | CID000000303 | |
| Drug | wortmannin from Penicillium funiculosum; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.35e-04 | 183 | 69 | 5 | 1668_UP | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.48e-04 | 185 | 69 | 5 | 4755_DN | |
| Drug | ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A | 2.60e-04 | 187 | 69 | 5 | 6955_DN | |
| Drug | Dicyclomine hydrochloride [67-92-5]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.60e-04 | 187 | 69 | 5 | 4581_UP | |
| Drug | AC1NAL8H | 2.61e-04 | 41 | 69 | 3 | CID004478772 | |
| Drug | Phenoxybenzamine hydrochloride [63-92-3]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.67e-04 | 188 | 69 | 5 | 6451_DN | |
| Drug | S-(+)-ibuprofen [51146-56-6]; Down 200; 19.4uM; PC3; HT_HG-U133A | 2.87e-04 | 191 | 69 | 5 | 6712_DN | |
| Drug | Beclomethasone dipropionate [5534-09-8]; Up 200; 7.6uM; PC3; HT_HG-U133A | 2.87e-04 | 191 | 69 | 5 | 4580_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 2.87e-04 | 191 | 69 | 5 | 5214_DN | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Down 200; 21.2uM; MCF7; HT_HG-U133A | 2.94e-04 | 192 | 69 | 5 | 3382_DN | |
| Drug | Promethazine hydrochloride [58-33-3]; Down 200; 12.4uM; HL60; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 3100_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 1148_UP | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; PC3; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 4286_DN | |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 3474_UP | |
| Drug | Cotinine (-) [486-56-6]; Down 200; 22.6uM; PC3; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 4650_DN | |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; PC3; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 5758_DN | |
| Drug | Dilazep dihydrochloride [20153-98-4]; Down 200; 6uM; PC3; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 7364_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.01e-04 | 193 | 69 | 5 | 7232_DN | |
| Drug | Prestwick_517 | 3.04e-04 | 106 | 69 | 4 | CID000003804 | |
| Drug | Pridinol methanesulfonate salt [6856-31-1]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.08e-04 | 194 | 69 | 5 | 7214_DN | |
| Drug | Josamycin [16846-24-5]; Up 200; 4.8uM; HL60; HG-U133A | 3.08e-04 | 194 | 69 | 5 | 2034_UP | |
| Drug | Tadjakonine [11087-94-8]; Up 200; 7.4uM; PC3; HT_HG-U133A | 3.08e-04 | 194 | 69 | 5 | 4599_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.08e-04 | 194 | 69 | 5 | 4990_DN | |
| Drug | alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.08e-04 | 194 | 69 | 5 | 3795_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HT_HG-U133A | 3.08e-04 | 194 | 69 | 5 | 4642_UP | |
| Drug | 5707885; Up 200; 50uM; MCF7; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 6433_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 3185_DN | |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; MCF7; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 6510_DN | |
| Drug | Azapropazone [13539-59-8]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 6522_DN | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; PC3; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 4224_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 5021_DN | |
| Drug | Rapamycin; Up 200; 0.1uM; HL60; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 1162_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 6648_DN | |
| Drug | Crotamiton [483-63-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | 3.16e-04 | 195 | 69 | 5 | 3050_DN | |
| Drug | SDMP | 3.21e-04 | 9 | 69 | 2 | CID000094924 | |
| Drug | coprogen | 3.21e-04 | 9 | 69 | 2 | CID006323272 | |
| Drug | AC1L32OA | 3.21e-04 | 9 | 69 | 2 | CID000107745 | |
| Drug | 5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA | 3.23e-04 | 196 | 69 | 5 | 833_UP | |
| Drug | (-)-Cinchonidine [485-71-2]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 5833_DN | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; HL60; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 1181_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 3739_DN | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 6053_UP | |
| Drug | Hippeastrine hydrobromide [22352-41-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 6042_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 6715_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 5593_UP | |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 3.23e-04 | 196 | 69 | 5 | 5666_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; HL60; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 3099_DN | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 7227_DN | |
| Drug | Meclofenamic acid sodium salt monohydrate [6385-02-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 7038_UP | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; PC3; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 5752_DN | |
| Drug | Meptazinol hydrochloride [59263-76-2]; Down 200; 14.8uM; PC3; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 4188_DN | |
| Drug | Nabumetone [42924-53-8]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 6487_DN | |
| Drug | Bumetanide [28395-03-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 7440_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 3723_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; HL60; HT_HG-U133A | 3.31e-04 | 197 | 69 | 5 | 2483_DN | |
| Disease | fatty liver disease (implicated_via_orthology) | 7.74e-07 | 31 | 68 | 4 | DOID:9452 (implicated_via_orthology) | |
| Disease | gallbladder cancer (is_implicated_in) | 3.29e-06 | 13 | 68 | 3 | DOID:3121 (is_implicated_in) | |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 7.78e-06 | 17 | 68 | 3 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Nephritis, Tubulointerstitial | 1.51e-05 | 21 | 68 | 3 | C0041349 | |
| Disease | Dent disease (implicated_via_orthology) | 1.57e-05 | 3 | 68 | 2 | DOID:0050699 (implicated_via_orthology) | |
| Disease | Renal glomerular disease | 2.01e-05 | 23 | 68 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 2.01e-05 | 23 | 68 | 3 | C4521256 | |
| Disease | Nephritis, Interstitial | 2.29e-05 | 24 | 68 | 3 | C0027707 | |
| Disease | migraine disorder, endometriosis | 2.49e-05 | 73 | 68 | 4 | EFO_0001065, MONDO_0005277 | |
| Disease | COVID-19, mortality | 4.65e-05 | 170 | 68 | 5 | EFO_0004352, MONDO_0100096 | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 5.21e-05 | 5 | 68 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.09e-04 | 7 | 68 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | osteopetrosis (implicated_via_orthology) | 1.09e-04 | 7 | 68 | 2 | DOID:13533 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.09e-04 | 7 | 68 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | primary bacterial infectious disease (implicated_via_orthology) | 1.86e-04 | 9 | 68 | 2 | DOID:0050338 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | 2.01e-04 | 523 | 68 | 7 | EFO_0005193 | |
| Disease | urate measurement | 2.07e-04 | 895 | 68 | 9 | EFO_0004531 | |
| Disease | Colorectal Carcinoma | 2.07e-04 | 702 | 68 | 8 | C0009402 | |
| Disease | adverse effect, response to xenobiotic stimulus | 3.47e-04 | 59 | 68 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 5.39e-04 | 15 | 68 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 5.39e-04 | 15 | 68 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 5.39e-04 | 15 | 68 | 2 | C0154091 | |
| Disease | body weight | 5.97e-04 | 1261 | 68 | 10 | EFO_0004338 | |
| Disease | Lipidemias | 6.96e-04 | 17 | 68 | 2 | C1706412 | |
| Disease | Hyperlipidemia | 6.96e-04 | 17 | 68 | 2 | C0020473 | |
| Disease | central corneal thickness | 7.41e-04 | 309 | 68 | 5 | EFO_0005213 | |
| Disease | Carcinoma of bladder | 7.82e-04 | 18 | 68 | 2 | C0699885 | |
| Disease | Glioblastoma | 8.17e-04 | 79 | 68 | 3 | C0017636 | |
| Disease | cortisol measurement | 9.68e-04 | 20 | 68 | 2 | EFO_0005843 | |
| Disease | citrulline measurement | 9.68e-04 | 20 | 68 | 2 | EFO_0009777 | |
| Disease | parental longevity | 9.73e-04 | 494 | 68 | 6 | EFO_0007796 | |
| Disease | Giant Cell Glioblastoma | 9.76e-04 | 84 | 68 | 3 | C0334588 | |
| Disease | Liver carcinoma | 1.11e-03 | 507 | 68 | 6 | C2239176 | |
| Disease | Kidney Diseases | 1.12e-03 | 88 | 68 | 3 | C0022658 | |
| Disease | Mammary Carcinoma, Human | 1.33e-03 | 525 | 68 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 1.33e-03 | 525 | 68 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 1.35e-03 | 527 | 68 | 6 | C1458155 | |
| Disease | congenital heart disease (is_implicated_in) | 1.40e-03 | 24 | 68 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | upper face morphology measurement | 1.48e-03 | 97 | 68 | 3 | EFO_0010949 | |
| Disease | Breast Carcinoma | 1.50e-03 | 538 | 68 | 6 | C0678222 | |
| Disease | Cerebral Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0750936 | |
| Disease | Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.52e-03 | 25 | 68 | 2 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.52e-03 | 25 | 68 | 2 | C0338070 | |
| Disease | brain cancer (implicated_via_orthology) | 1.64e-03 | 26 | 68 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | diabetes mellitus (implicated_via_orthology) | 1.64e-03 | 26 | 68 | 2 | DOID:9351 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.64e-03 | 26 | 68 | 2 | C0334582 | |
| Disease | uromodulin measurement | 1.64e-03 | 26 | 68 | 2 | EFO_0021778 | |
| Disease | Anaplastic astrocytoma | 1.77e-03 | 27 | 68 | 2 | C0334579 | |
| Disease | Iniencephaly | 1.90e-03 | 28 | 68 | 2 | C0152234 | |
| Disease | Acrania | 1.90e-03 | 28 | 68 | 2 | C0702169 | |
| Disease | Tethered Cord Syndrome | 1.90e-03 | 28 | 68 | 2 | C0080218 | |
| Disease | Spinal Cord Myelodysplasia | 1.90e-03 | 28 | 68 | 2 | C0344479 | |
| Disease | Exencephaly | 1.90e-03 | 28 | 68 | 2 | C0266453 | |
| Disease | Neurenteric Cyst | 1.90e-03 | 28 | 68 | 2 | C0027806 | |
| Disease | Diastematomyelia | 1.90e-03 | 28 | 68 | 2 | C0011999 | |
| Disease | Craniorachischisis | 2.04e-03 | 29 | 68 | 2 | C0152426 | |
| Disease | Child Development Disorders, Specific | 2.04e-03 | 29 | 68 | 2 | C0085997 | |
| Disease | Child Development Deviations | 2.04e-03 | 29 | 68 | 2 | C0085996 | |
| Disease | diabetes mellitus (is_implicated_in) | 2.04e-03 | 29 | 68 | 2 | DOID:9351 (is_implicated_in) | |
| Disease | Glioblastoma Multiforme | 2.17e-03 | 111 | 68 | 3 | C1621958 | |
| Disease | diverticular disease | 2.18e-03 | 236 | 68 | 4 | EFO_0009959 | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.18e-03 | 30 | 68 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | Neural Tube Defects | 2.18e-03 | 30 | 68 | 2 | C0027794 | |
| Disease | Developmental Disabilities | 2.18e-03 | 30 | 68 | 2 | C0008073 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AHFTDDGRWNDDVCQ | 256 | P07306 | |
| DCSFNHGICDWKQDR | 401 | Q8IUX8 | |
| QFGHCFSWGENREEA | 556 | Q13085 | |
| NTCNHDEDTWVECED | 226 | O43866 | |
| SLEQCQHRFWGFHDC | 321 | O43866 | |
| HEQCCWTSNETTFED | 111 | P51793 | |
| CDDGWDLSDAHVVCQ | 1061 | Q9NR16 | |
| CKDAWHAEVSCRDSQ | 156 | Q7Z419 | |
| NHCDQGCNSEECGWD | 1516 | Q04721 | |
| QDFRCLWCNSTVHDD | 426 | Q5KSL6 | |
| SAECEWDGLDCAEHV | 1551 | P46531 | |
| NCHWEGCAREFDTQE | 481 | P10071 | |
| NRCVFESWVCDSQDD | 461 | Q9Y561 | |
| HCIQARWKCDGDDDC | 856 | Q9NZR2 | |
| RDEFHCDSSCSWNQF | 2711 | Q9NZR2 | |
| TQWQCDGDFDCPDHS | 2861 | Q9NZR2 | |
| DHWRCDSQNDCSDNS | 3491 | Q9NZR2 | |
| SDWEGNFCEQESNEC | 761 | Q5T1H1 | |
| FFDRAGHCEDEGCSW | 321 | Q96N19 | |
| NCRDVDECAWDAHLC | 4666 | Q8NDA2 | |
| DLQADCNCALESWHD | 111 | Q8N386 | |
| CNCALESWHDIRRDN | 116 | Q8N386 | |
| RCIPEHWTCDGDNDC | 1026 | Q07954 | |
| LSSRQWECDGENDCH | 2871 | Q07954 | |
| AWNDRDNRCDICATH | 176 | Q2KJY2 | |
| ESNTCCSDWQRHFDV | 1036 | Q9UHC1 | |
| EDEASCCRWGAQHAG | 16 | A5PLL7 | |
| HRGNCQTCWQASFDE | 731 | Q12986 | |
| VWESLHNVDGDSCFC | 346 | Q8N5J2 | |
| VAWRCDGFTECEDHS | 1266 | O75581 | |
| DCRWDGCSQEFDSQE | 236 | P08151 | |
| DGSNWGQEQREDHLC | 61 | P05162 | |
| GNCIHRAWLCDRDND | 1281 | P98164 | |
| WAVCNGVDDCRDNSD | 3696 | P98164 | |
| WICDHYNDCGDNSDE | 3776 | P98164 | |
| QDWRCVNFSFCQDLH | 276 | P06213 | |
| HDLWCEECNNAHASV | 171 | Q9NQV6 | |
| RDQDSWVDGDHCRNC | 281 | Q92832 | |
| DIDECALRTHTCWND | 596 | Q92832 | |
| CTEAEGQRWHENHFC | 161 | Q2TBC4 | |
| WLQCSGHTDRCDEAQ | 431 | P07333 | |
| IGCDNCNEWFHGDCI | 41 | Q9P0U4 | |
| WDEEKRHCFANICDA | 1791 | Q9UFH2 | |
| DVNECAFWNHGCTLG | 356 | P01133 | |
| TWDRDHDNYEGNCAE | 236 | Q08830 | |
| CCWNSEHVTFEERDK | 171 | P51795 | |
| AHGDRWREDDCTFCQ | 411 | Q9NZV1 | |
| GYNDCDDWSDEAHCN | 291 | Q9Y5Q5 | |
| DDWSDEAHCNCSENL | 296 | Q9Y5Q5 | |
| WGECDSTDDCIEHNI | 696 | Q6IA86 | |
| IQHFCNCDADKDEWT | 731 | Q8WYK1 | |
| TNECREDEMCWNYHG | 341 | Q12805 | |
| WESLHNVDGDGNFCD | 476 | Q8NBR6 | |
| WSSDDCALHGHCEQV | 166 | Q9NWD8 | |
| DFWRAVCEADQSHGG | 261 | O14545 | |
| EDDEGAQWNCTACTF | 661 | Q9NYJ8 | |
| NWGHRSDTEANEREC | 321 | Q9HAT8 | |
| CHLNDGDEVVCDWCA | 806 | P25391 | |
| QWEEQHRGRSCEDFQ | 831 | Q96EP0 | |
| CGHNFCEACIQDFWR | 56 | Q86WT6 | |
| RNNEEWTVDSCTECH | 326 | P07996 | |
| SIDEDCKSNNGRWHC | 301 | P07911 | |
| GRWHCQCKQDFNITD | 311 | P07911 | |
| TDENGWQEIHQACRF | 246 | Q9BYB0 | |
| VFHEEGICQDWSHCS | 686 | Q9H5L6 | |
| QQDFVADWCSEGECL | 611 | Q8IYQ7 | |
| CDCDVGWRGVHCDNA | 1416 | Q8WWQ8 | |
| DELGCQGHESALWQC | 621 | Q4G0T1 | |
| DNFAFDVSHECAWGC | 141 | Q2VWA4 | |
| IHDFDCQWRDDERNC | 141 | Q09FC8 | |
| ACRDRKDCNFFQWED | 66 | Q9H5U6 | |
| RDFQCSSFRDDWECN | 111 | Q969W8 | |
| EDFDHHCKWVNNCIG | 136 | Q8WVZ1 | |
| LCWCGVQHDSGTEQE | 556 | Q1EHB4 | |
| DGWDCENQEGHLRQS | 36 | Q86UD4 | |
| DWDNEYCSNECVVKH | 586 | O94842 | |
| EQSNHVCFWEECPRE | 296 | O95409 | |
| HQCNECARTFWDNSE | 421 | Q96NJ6 | |
| DCGEEQTRWHFDAQA | 336 | Q8TEU8 | |
| FWRCDGQVDCDNGSD | 86 | P01130 | |
| VNESSWHEECLQCAA | 71 | O60663 |